Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Sun Pharma Advanced Research Company Limited (NSE: SPARC), ISIN INE232I01014 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SPARC last traded at ₹209.30 (+8.15%), with a 52-week range of ₹108.00 to ₹289.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 65.67%, FIIs 3.74%, DIIs 0.11%, mutual funds 0.10%.
EquiSense Score (ECS): 57/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.